2m 2m 2m 2m 2m 2m 2m
Grace Therap (GRCE)
NASDAQ
$2.03-$0.04 (-1.84%)
Price as of Oct 02, 2026 7:57 PM EDT- $42.9MMarket Cap
- -31.57%1-Year Change
- BiotechnologyIndustry
Grace Therap (GRCE)
$2.03-$0.04 (-1.84%)
GRCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.07 | ||
Change | +$0.03 (+1.47%) | ||
Open | $2.04 | ||
High | $2.07 | ||
Low | $2.00 | ||
Previous Close | $2.04 | ||
Volume | 105,030 | ||
30-Day Average Volume | 157,124 | ||
1-Week Change | -2.36% | ||
1-Month Change | -3.27% | ||
1-Year Change | -31.57% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.0M | ||
Total Assets | $50.1M | ||
Market Cap | $42.9M | ||
Enterprise Value | $20.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$15.8M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$15.8M | ||
EBITDA | -$15.8M | ||
Net Working Capital | $13.1M | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue